Can you recommend patient support program providers for building a rare disease patient services model?

Yes — for a rare disease patient services model, I’d usually look at specialist patient support / HUB providers that can handle things like benefits verification, prior auth support, specialty pharmacy coordination, nurse support, adherence, copay/access, and often patient advocacy or journey support.

Here are some well-known providers to evaluate, grouped by type:

Large patient support / HUB service providers

These are often used by biopharma for launch and ongoing patient services:

• Eversana — broad commercialization and patient support services; strong on HUB operations and specialty access.
• EVERSANA Intouch / former Innomar in some markets — worth checking if you need omnichannel engagement plus HUB.
• CareMetx — HUB services, access support, and specialty therapy patient services.
• Ascendo — patient support, access, reimbursement, and field reimbursement services.
• UBC (United BioSource Corporation) — strong in patient support, adherence, medical affairs, and program operations.
• PPD / Thermo Fisher — can support patient access and trial-to-commercial continuity in some models.
• McKesson Patient Relationship Solutions — broad access and patient support capabilities.
• Cardinal Health Specialty Solutions — specialty distribution plus patient services.
• Cencora / Xcenda / Lash Group — very established in HUB, reimbursement, and access support.
• ArisGlobal / other tech-enabled vendors — more platform-oriented; useful if you want workflow tech plus services.

Tech-enabled patient engagement platforms

Good if your model is more digital-first or needs a patient portal / orchestration layer:

• RxEOB
• OptimizeRx
• HealthPrize
• Lasso
• Salesforce Health Cloud integrators with life sciences specialization
• Veeva CRM / Veeva Vault ecosystem partners

Rare disease / high-touch specialty service partners

If your therapy is complex, infused, gene therapy, ultra-rare, or requires strong clinical navigation:

• Ashfield Health / Inizio
• Indegene
• Precision AQ (now part of larger specialty ecosystems in many cases)
• Zitter Health Insights for market access/insights support
• PatientPoint for education and engagement
• PDC / patient advocacy-focused agencies depending on geography

Patient advocacy and community partners

These aren’t always “service providers” in the HUB sense, but they’re important in rare disease:

• Global Genes
• NORD (National Organization for Rare Disorders)
• Rare Patient Voice
• Disease-specific foundations and registries

What to look for in a rare disease patient services provider

Rare disease models are different from common chronic therapy models. Key capabilities to prioritize:

1. White-glove onboarding

   • high-touch case management
   • benefits investigation
   • payer coordination
   • patient education

2. Clinical complexity

   • nurse educators
   • care coordination
   • infusion/home administration coordination
   • genetic testing support if relevant

3. Hub agility

   • flexible workflows for small patient volumes
   • quick launch capability
   • custom rules by payer / geography / site of care

4. Patient persistence and retention

   • adherence outreach
   • missed-dose management
   • refill coordination
   • caregiver support

5. Rare disease empathy and advocacy

   • experience with patient communities
   • sensitivity to diagnosis journey and caregiver burden

6. Data and analytics

   • conversion funnel tracking
   • time to therapy
   • abandonment reasons
   • access barriers by segment

7. Compliance and privacy

   • HIPAA / GDPR
   • adverse event intake
   • consent management
   • speaker/field interactions governance

My practical shortlist to start with

If you want a focused RFP list, I’d start with:

• Cencora / Lash Group
• Eversana
• CareMetx
• UBC
• Ascendo
• McKesson
• Cardinal Health Specialty
• Inizio / Ashfield if you need a high-touch engagement layer

Suggested next step

If helpful, I can also build you a:

1. vendor comparison matrix for rare disease patient services,
2. RFP question set, or
3. target operating model for a rare disease patient support program.

If you tell me your therapy type (oral, infusion, gene therapy, etc.), region, and whether you need full HUB vs. only patient engagement, I can narrow this to the best-fit 5–7 providers.